“The global ophthalmology PACS market is projected to grow at 8.5% during the forecast period.”
The global ophthalmology PACS market is projected to reach USD 160.2 million by 2023 from an estimated USD 106.6 million in 2018, at a CAGR of 8.5% during the forecast period. Growth in this market is mainly driven by the rapid growth in the geriatric population, rising prevalence of eye diseases, limited number of ophthalmologists, government initiatives to encourage the adoption of EHR/EMR, and the increasing adoption of teleophthalmology. On the other hand, high implementation and maintenance costs are expected to limit market growth during the forecast period. Poor compatibility with informatics standards may also challenge market growth to a certain extent.
“By delivery model, web/cloud-based models are expected to grow at the highest CAGR during the forecast period.”
On the basis of delivery model, the ophthalmology PACS market is segmented into on-premise and web/cloud-based models. The web/cloud-based PACS segment is expected to grow at the highest CAGR during the forecast period. Cloud-based models do not incur any major setup charges. Additionally, the maintenance and support service charges are also inclusive of the subscription fees, making these delivery modes more affordable for customers.
“Asia to witness high growth during the forecast period.”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to grow at the highest CAGR during the forecast period. The high growth of this regional segment is attributed to the increasing demand for diagnostic imaging procedures, growing medical tourism, increasing geriatric population and incidence of age-related eye diseases, growing awareness on healthcare services, rising healthcare expenditure, and developing healthcare infrastructure.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 30%; Tier 2 - 42%; Tier 3 - 28%.
• By Designation: C-level- 25%; D-level- 45%; others--30%.
• By Region: North America-34%; Europe-28%; Asia -32%; RoW-6%.
List of companies profiled in the report
• Carl Zeiss Meditec AG (Germany)
• Topcon Corporation (Japan)
• Heidelberg Engineering (Germany)
• Sonomed Escalon (US)
• Visbion (UK)
• EyePACS (US)
• IBM Corporation (Merge Healthcare) (US)
• VersaSuite (US)
• Medical Standard (South Korea)
• ScImage (US)
The report provides an overview of the ophthalmology PACS market. It aims at estimating the market size and growth potential of this market across different segments such as type, delivery model, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the ophthalmology PACS market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.